Skip to content
ClinCalc Pro
Menu
Anaesthesia / Critical Care Surgery Emergency Medicine Strong — internationally used; endorsed by NBCR and ABA guidelines

Parkland Formula for Burns Fluid Resuscitation

Calculates the volume of IV fluid (Hartmann's/Ringer's lactate) required in the first 24 hours of a major burn. Half given in the first 8h post-burn; remainder over next 16h.

Used in: Burns

Score interpretation

Small Volume Replacement ≥ 0

Total 24h Parkland volume < 4 L. Moderate burn resuscitation.

→ IV Hartmann's/Ringer's lactate. First half over hours 1–8 post-burn (not from time of presentation). Second half over hours 9–24. Titrate to urine output 0.5–1 mL/kg/h. Monitor for over-resuscitation (abdominal compartment syndrome).

Large Volume Replacement ≥ 4000

Total 24h Parkland volume 4–9 L. Significant burn resuscitation required.

→ Burns unit transfer. IV Hartmann's as calculated. Hourly urine output monitoring (aim 0.5–1 mL/kg/h). NG feeding within 6h. Escharotomy if circumferential burns. Senior burn surgery input.

Major Burns — Massive Resuscitation ≥ 9000

Total 24h Parkland volume > 9 L. Major burn — risk of massive fluid shifts and complications.

→ Immediate major burns centre transfer (if > 15% TBSA or special areas: face, hands, genitalia, perineum, circumferential). Airway assessment and early intubation if inhalation injury. Target UO 0.5–1 mL/kg/h. Monitor for abdominal compartment syndrome, pulmonary oedema. Colloid after 8–12h.

Interpretation bands for the Parkland Formula. Apply clinical judgement and local guidance.

References

Related

Curated clinical cross-links plus same-class fallbacks.

📚 MRCEM Revision

Featured in these MRCEM clinical pathways

The Parkland Formula is covered in detail — with RCEM/NICE evidence base, indications and pitfalls — in the following exam-focused pathways on our sister siteReviseMRCEM.

MRCEM Primary / Intermediate / OSCE candidates: each pathway includes exam-style questions, RCEM/NICE citations, and FAQ summaries.

Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.